Related Experiment Videos
Autoimmune hepatitis overlapping with primary sclerosing cholangitis
Junko Takiguchi1, Hiromasa Ohira, Tsuyoshi Rai
1Second Department of Internal Medicine, Fukushima Medical University School of Medicine.
Internal Medicine (Tokyo, Japan)
|September 27, 2002
Summary
This report details a rare case of autoimmune hepatitis (AIH) overlapping with primary sclerosing cholangitis (PSC) in Japan. Treatment normalized transaminases but not cholestatic enzymes, suggesting prognosis depends on cholestatic feature response.
Area of Science:
- Hepatology
- Gastroenterology
- Immunology
Background:
- Autoimmune hepatitis (AIH) is a chronic liver disease characterized by autoimmune activity against hepatocytes.
- Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease involving inflammation and fibrosis of the bile ducts.
- The overlap of AIH and PSC is uncommon, with limited documented cases globally and none previously reported in Japan.
Observation:
- A 36-year-old woman presented with clinical and diagnostic features consistent with AIH overlapping with PSC.
- Diagnosis was confirmed using established criteria for AIH and characteristic findings from endoscopic retrograde cholangiography (ERC).
Findings:
- Initial treatment with prednisone, azathioprine, and ursodeoxycholic acid led to normalization of transaminase levels within one month.
- However, cholestatic enzyme levels remained elevated despite treatment, indicating persistent biliary involvement.
- The patient's diagnosis was established based on AIH criteria and ERC findings.
Implications:
- This case highlights the rare occurrence of AIH overlapping with PSC, particularly in the Japanese population.
- The differential response of transaminase and cholestatic enzyme levels to treatment suggests distinct pathophysiological components.
- Monitoring the response of cholestatic features to therapy is crucial for predicting the long-term prognosis in patients with AIH overlapping PSC.